Low cure rate of Helicobacter pylori infection with omeprazole and furazolidone dual therapy for one week

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 3, 1997, Pages 533-535

  Van Zwet, A A ^a   Thijs, J C ^a   Van Der Wouden, E J ^a   Kooy, A ^a  

^a Bethesda Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; FURAZOLIDONE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; UREASE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DRUG TOLERANCE; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; PEPTIC ULCER; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0030749769     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00166.x     Document Type: Article

References (20)

1. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
2. Thijs JC, Kuipers EJ, Van Zwet AA, Pena AS, De Graaff J. Treatment of Helicobacter pylori infections. Q J Med 1995; 88: 369-89.
3. Zheng ZT, Wang YB. Treatment of peptic ulcer disease with furazolidone. J Gastroenterol Hepatol 1992; 7: 533-7.
4. Zheng ZT, Wang ZY, Chu YX, et al. Double-blind short-term trial of furazolidone in peptic ulcer. Lancet 1985; i: 1048-9.
5. Zhao HY, Li G, Guo J, et al. Furazolidone in peptic ulcer. Lancet 1985; ii: 276-7.
6. Goodwin CS, Blake P, Blincow G. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother 1986; 17: 309-14.
7. Morgan D, Kraft W, Bender M, Pearson A. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gastroenterology 1988; 95: 1178-84.
8. Gutiérrez O, Angel A, Segura AM, Genta RM, Graham DY. Effectiveness of triple therapy for Helicobacter pylori in countries where metronidazole resistance is common. Gastroenterology 1996; 110: A126(Abstract).
9. Haas CE, Nix DE, Schentag JJ. In vitro selection of resistant Helicobacter pylori. Antimicrob Agents Chemother 1990; 34: 1637-41.
10. Altamirano A, Bondani A. Adverse reactions to furazolidone and other drugs. Scand J Gastroenterol 1989; 24 (Suppl. 169): 70-80.
11. Arvind AS, Cook RS, Tabaqchali S, Farthing MJG. One-minute endoscopy room test for Campylobacter pylori. Lancet 1988; i: 704.
12. Van Zwet AA, Thijs JC, Roosendaal R, Kuipers EJ, Pena S, De Graaff J. Review: Practical diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996; 8: 501-7.
13. De Boer WA, Thijs JC, Borody TJ, Graham DY, O'Morain C, Tytgat GNJ. Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. Eur J Gastroenterol Hepatol 1996; 8: 641-4.
14. De Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients. Eur J Gastroenterol Hepatol 1995; 7: 1189-94.
15. Noach LA, Bertola MA, Schwartz MP, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: an evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 1994; 6: 585-92.
16. De Boer WA, Tytgat GNJ. 90% Cure: which anti-Helicobocter therapy can achieve this goal? Am J Gastroenterol 1995; 90: 1381-2 (Editorial).
17. Graham DY. A reliable cure for Helicobacter pylori infection? Gut 1995; 37: 154-6.
18. van Zwet AA, de Boer WA, Schneeberger PM, Weel J, Jansz AR, Thijs JC. Prevalence of primary Helicobacter pylori resistance to metronidazole and to clarithromycin in the Netherlands. Eur J Clin Microbiol Inf Dis 1996; 15: 861-1.
19. Reddy R, Osato M, Gutiérrez O, Kim JG, Graham DY. Metronidazole resistance is high in Korea and Columbia and appears to be rapidly increasing in the US. Gastroenterology 1996; 110: A238 (Abstract).
20. Ling TWK, Cheng AFB, Sung JJY, Yiu PYL, Chung SSC. An increase in Helicobacter pylori strains resistant to metronidazole: A five year study. Helicobacter 1996; 1: 57-61.